Meghan V. Joyce - Aug 4, 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Meghan Verena Joyce
Stock symbol
GH
Transactions as of
Aug 4, 2022
Transactions value $
$0
Form type
4
Date filed
9/7/2022, 04:36 PM
Previous filing
Jun 17, 2022
Next filing
Oct 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +796 $0.00 796 Aug 4, 2022 Direct
transaction GH COMMON STOCK Options Exercise $0 +66 +8.29% $0.00 862 Sep 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -796 -24.99% $0.00 2.39K Aug 4, 2022 COMMON STOCK 796 $0.00 Direct F1, F2
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -66 -2.76% $0.00 2.32K Sep 4, 2022 COMMON STOCK 66 $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter.
F2 Not applicable to Restricted Stock Units.